NAVICAN Revenue and Competitors
Estimated Revenue & Valuation
- NAVICAN's estimated annual revenue is currently $8.4M per year.
- NAVICAN received $15.0M in venture funding in June 2017. 0
NAVICAN Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is NAVICAN?
NAVICAN delivers precision cancer care. All patients deserve access to precision cancer care - the right therapy at the right time to ensure better outcomes and reduced healthcare costs. Today many people don't get the precision therapy they need, and we're building a team of exceptional professionals because we believe we can do better. Based on proven processes developed through years of experience and clinical best practices of Intermountain Healthcare, NAVICAN was created to transform advances in precision medicine into precision cancer care for patients everywhere that advanced therapies are available. Expert prioritized therapy recommendations and experienced treatment navigators will simplify the path to drug and clinical trial access. At the same time, well help patients and their caregivers navigate often frustrating administrative processes. We're driven by an impatience to make more precision therapy options available to more cancer patients. If you have a passion to help people, a desire to grow, and you excel at what you do, join us at NAVICAN to make a positive impact on the world.keywords:N/A
Number of Employees
Employee Growth %
Intermountain Healthcare company Navican has partnered with SeraCare Life Sciences and Royal Philips to launch its TheraMap Precision
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|